Executive Summary
The Procter & Gamble Company (PG) delivered solid performance in Q3 2024, with organic sales growth of 3% year-over-year driven primarily by pricing and stable volumes despite ongoing challenges in certain markets. Notably, P&G's core EPS rose to $1.52, an 11% increase compared to the previous year, showcasing resilience in profitability amid a volatile operating environment. Management expressed confidence in achieving FY2024 guidance for core EPS growth of 10-11%, highlighting strategic investments in brand and product superiority, although headwinds from inflation and currency fluctuations remain a concern.
Key Performance Indicators
Revenue
20.20B
QoQ: -5.81% | YoY:0.63%
Gross Profit
10.34B
51.20% margin
QoQ: -8.47% | YoY:7.00%
Operating Income
4.46B
QoQ: 0.61% | YoY:4.99%
Net Income
3.75B
QoQ: 8.25% | YoY:10.51%
EPS
1.56
QoQ: 8.33% | YoY:10.64%
Revenue Trend
Margin Analysis
Key Insights
- **Revenue:** $20.20 billion, up 3% YoY.
- **Net Income:** $3.75 billion, up 10.51% YoY.
- **EPS:** $1.52 (diluted), up 8.33% QoQ.
- **Gross Profit Margin:** 51.2%, up from 48.2% YoY.
- **Operating Income Margin:** 22.1%, reflecting solid cost management strategies.